 | Joyce Mordenti, Ph.D. Vice President, Translational Medicine Dr. Mordenti joined Medivation in July 2007 as senior director, translational medicine and was promoted in February 2008 to vice president, translational medicine. Dr. Mordenti has more than 20 years of clinical and preclinical experience at multidisciplinary drug discovery and development organizations. Prior to joining Medivation, she was senior director of drug metabolism and pharmacokinetics for Celera Genomics (formerly Axys). Before that, she held positions of increasing seniority at Genentech, including group leader/senior scientist of experimental therapeutics in the Research Division. Earlier in her career, she served as associate director of the Clinical Drug Studies Unit at the University of California, San Francisco, School of Pharmacy. She received a Ph.D. in pharmaceutical sciences from the University of Connecticut and received training as a clinical fellow at the University of California, San Francisco School of Medicine. Top |
|
